This content is machine translated Atopic dermatitis Long-term efficacy of baricitinib proven In adult patients with moderate to severe atopic dermatitis, long-term therapy with the JAK inhibitor baricitinib maintained improvements achieved after 16 weeks for 68 weeks, new data show. A pooled…
View Post 5 min This content is machine translated Stroke prevention Low-threshold atrial fibrillation detection and early rhythm control. Given the high risk of stroke in patients with atrial fibrillation (VHF), current guidelines, such as those of the European Society of Cardiology (ESC), recommend screening for VHF in certain…
View Post 2 min This content is machine translated Digital Health Neurodermatitis patients benefit from Nia App With the new cooperation between aha! Allergy Center Switzerland and Nia Health, more sufferers in Switzerland should use the award-winning app in their daily lives. The focus is on the…
View Post 2 min This content is machine translated Neuroimmunology Podcasts provide insight into rare diseases Rare diseases have one thing in common: only a few people are really familiar with the symptoms and possible treatment options. Three different podcasts now take you into the exciting…
View Post 2 min This content is machine translated Spinal muscular atrophy Single-agent gene therapy shows transformative therapeutic benefit New trial data demonstrate age-appropriate development and achievement of motor milestones in presymptomatic children with SMA using single-agent gene therapy, without any respiratory or nutritional support or serious treatment-related adverse…
View Post 2 min This content is machine translated Plaque psoriasis Secukinumab ready-to-use 300 mg injection convinces The EMA-approved new route of administration for the IL-17A inhibitor allows the recommended dosage to be administered in a single injection. Data analyses of the pivotal phase IIIb MATURE study…
View Post 4 min This content is machine translated Non-resectable BRAF-mutated melanoma 5-year data from COLUMBUS study support continued long-term benefits After five years of follow-up in the COLUMBUS study, it is clear that patients with non-resectable or metastatic melanoma with a BRAFV600 mutation benefit long-term from encorafenib in combination with…
View Post 2 min This content is machine translated Diabetes Therapy Tirzepatide convinces with superior HbA1c and weight reduction The dual GLP-1/GIP receptor agonist tirzepatide is currently being evaluated in Phase III clinical trials. In adult type 2 diabetics at increased cardiovascular risk, tirzepatide resulted in superior HbA1c and…
View Post 1 min This content is machine translated Coronary heart disease Non-invasive diagnostics for suspected cases When coronary artery disease is suspected, the question arises as to the best diagnostic procedure. Unnecessary invasive examinations must be avoided , but at the same time the individual risk must…
View Post 2 min This content is machine translated Antibody antigen binding fragment European license for bentracimab acquired Bentracimab is a novel recombinant human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet effect of ticagrelor in severe bleeding and urgent surgical procedures. Alfasigma has now acquired the…
View Post 1 min This content is machine translated Intensive Care Medicine Seraph 100″ adsorber from Exthera Medical expands product range Fresenius Medical Care, the world’s leading provider of products and services for people with kidney disease, is now marketing the “Seraph 100 Microbind Affinity Blood Filter” adsorber from ExThera Medical…
